Stocks
Axsome Therapeutics (AXSM) P/E US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -28.8 | -10.5 | -16.8 | -15.9 | -15.1 | -9.97 | ||
| Changes by years, y/y, % | -43% | -63% | +59% | -5% | -5% | +43.9% | |||
Axsome Therapeutics. P/E
Axsome Therapeutics. P/E, changes, %
Axsome Therapeutics (AXSM) P/E US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| P/E | ? | -15.9 | -15.7 | -12.8 | -12.4 | -13.9 | -9.97 | |
| Changes by years, y/y, % | +42% | -7% | -20% | -24% | -12% | |||
| Changes by quarters, q/q, % | -3% | -1% | -19% | -3% | +12% | |||
